The pathogenesis of hepatocellular carcinoma: ERK/ULK1/NCOA4-mediated inhibition of iron autophagy, and Epimedium extract targeted modulation of this pathway to treat hepatocellular carcinoma DOI
Liying Han, Xun Tian, Xinxin Yang

et al.

Phytomedicine, Journal Year: 2025, Volume and Issue: unknown, P. 156666 - 156666

Published: March 1, 2025

Language: Английский

The Role of Cholesterol Metabolism and Its Regulation in Tumor Development DOI Creative Commons

Yongmei Wu,

Wenqian Song,

Su Min

et al.

Cancer Medicine, Journal Year: 2025, Volume and Issue: 14(7)

Published: March 27, 2025

ABSTRACT Background Within the tumor microenvironment, cells undergo metabolic reprogramming of cholesterol due to intrinsic cellular alterations and changes in extracellular milieu. Furthermore, within this microenvironment influences immune landscape tumors, facilitating evasion consequently promoting tumorigenesis. These biological involve modifications numerous enzymes associated with uptake synthesis, including NPC1L1, SREBP, HMGCR, SQLE, PCSK9. Review This review systematically summarizes role metabolism its cancer progression, examines mechanisms through which dysregulation affects discusses recent advancements therapies that target metabolism. Conclusion Targeting metabolism‐related can inhibit growth, reshape landscapes, rejuvenate antitumor immunity, offering potential therapeutic avenues treatment.

Language: Английский

Citations

2

The pathogenesis of hepatocellular carcinoma: ERK/ULK1/NCOA4-mediated inhibition of iron autophagy, and Epimedium extract targeted modulation of this pathway to treat hepatocellular carcinoma DOI
Liying Han, Xun Tian, Xinxin Yang

et al.

Phytomedicine, Journal Year: 2025, Volume and Issue: unknown, P. 156666 - 156666

Published: March 1, 2025

Language: Английский

Citations

0